Vaccine News and Research

Latest Vaccine News and Research

Study pinpoints potential transmission advantage of SARS-CoV-2 variant B.1.1.7

Researchers in the UK have shown that the increased transmissibility of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) lineage B.1.1.7 that emerged in the UK during the coronavirus disease 2019 (COVID-19) pandemic does not appear to be the result of increased viral replication or immune escape.

25 Feb 2021

Study: Majority of COVID-19 hospitalizations attributable to four pre-existing conditions

A modeling study suggests a majority of adult COVID-19 hospitalizations nationwide are attributable to at least one of four pre-existing conditions: obesity, hypertension, diabetes, and heart failure, in that order.

25 Feb 2021

Have a case of a Covid variant? No one is going to tell you

Covid-19 infections from variant strains are quickly spreading across the U.S., but there's one big problem: Lab officials say they can't tell patients or their doctors whether someone has been infected by a variant.

25 Feb 2021

SNX-5422 could make an effective COVID-19 prophylactic, says study

SNX-5422 is a heat shock protein 90 (Hsp90) inhibitor currently undergoing clinical trials as a cancer therapeutic. A recent study examines the applicability of repurposing the drug towards severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) replication inhibition.

25 Feb 2021

Covid vaccine websites violate disability laws, create inequity for the blind

Many Covid vaccination registration and information websites at the federal, state and local levels violate disability rights laws, hindering the ability of blind people to sign up for a potentially lifesaving vaccine, a KHN investigation has found.

25 Feb 2021

International cooperation is key to get equal access to COVID-19 vaccines

Almost 130 countries are yet to receive a single COVID-19 vaccine dose, as ten high-income countries secure the majority.

25 Feb 2021

Research shows how antibodies attach to and block Zika virus

The Zika outbreak of 2015 and 2016 are having lasting impacts on children whose mothers became infected with the virus while they were pregnant.

25 Feb 2021

AI-mediated analysis of vaccinated patients affirms safety of SARS-CoV-2 vaccines

A new study provides a timely answer to many of these fears, by reporting on the results of an analysis of over 31,000 vaccine recipients with respect to immediate adverse effects, reported within 21 days, of the first and/or second doses of the vaccine.

25 Feb 2021

Study of children hospitalized with COVID-19 shows 2% mortality

The COVID-19 pandemic caused by SARS-CoV-2 has been observed to be less serious in infants and children. However, this age group is also subject to certain complications following infection. A new study describes the findings of an observational study of children hospitalized with SARS-CoV-2 infection in several different hospitals across three countries.

25 Feb 2021

New vaccine, enhanced surveillance needed to combat childhood pneumonia

A rise in vaccine-resistant bacteria shows the need for a new vaccine to fight childhood empyema after a spike in hospitalisations, a new UNSW study reveals.

25 Feb 2021

Travel bans are effective only in the first phases of pandemic

Travel bans have been key to efforts by many countries to control the spread of COVID-19. But new research aimed at providing a decision support system to Italian policy makers, recently published in the Journal of the Royal Society Interface, suggests that reducing individual activity (i.e., social distancing, closure of non-essential business, etc.) is far superior in controlling the dissemination of Sars-CoV-2, the virus that causes COVID-19.

25 Feb 2021

New approach can reduce unnecessary evaluations of swollen lymph nodes after COVID-19 vaccination

Swelling of lymph nodes in the armpit area is a normal response to COVID-19 vaccinations, but when they are seen on mammograms, they can be mistaken for nodes that are swollen because of cancer. In some cases, the nodes are biopsied to confirm they are not cancer.

25 Feb 2021

Lab study of South African SARS-CoV-2 variant and Moderna vaccine: reduced neutralization, but still protective

Researchers from the US recently compared antibody binding and viral neutralization against 2 SARS-CoV-2 variants that emerged in different parts of the world. The researchers used sera from spike mRNA vaccinated and naturally infected individuals against a circulating B.1 variant and the emerging B.1.351 variant. The study is published on the preprint server bioRxiv.

24 Feb 2021

Full characterization of mammalian-produced SARS-CoV-2 receptor binding domains

A research paper recently uploaded to the preprint server bioRxiv by Dominguez-Vega et al. (23rd Feb, 2021) describes an in-depth structural analysis of the RBD of the spike protein expressed in mammalian Chinese hamster ovary (CHO) cells and human embryonic kidney (HEK293) cells, providing a new understanding of protein structure and function.

24 Feb 2021

Study takes a closer look at the impact of COVID-19 pandemic on dental hygienists

Despite having been designated as high risk for COVID-19 by the Occupational Safety and Health Administration, a new study finds 3.1 percent of dental hygienists have had COVID-19 based on data collected in October 2020.

24 Feb 2021

Survey finds highest ever vaccination rates during the 2020-2021 flu season

More U.S. adults reported receiving or planning to receive an influenza vaccination during the 2020-2021 flu season than ever before, according to findings from a December 2020 national survey.

24 Feb 2021

GW team to play a role in Sanofi COVID-19 vaccine clinical trial

The George Washington University announced today its participation in a Sanofi COVID-19 vaccine clinical trial. GW was selected as one of approximately 25 sites in the United States to launch a phase 2 study for its adjuvanted recombinant protein-based COVID-19 vaccine candidate.

24 Feb 2021

Vaccine News and Research

Latest Vaccine News and Research

Study pinpoints potential transmission advantage of SARS-CoV-2 variant B.1.1.7

Study: Majority of COVID-19 hospitalizations attributable to four pre-existing conditions

Have a case of a Covid variant? No one is going to tell you

SNX-5422 could make an effective COVID-19 prophylactic, says study

Covid vaccine websites violate disability laws, create inequity for the blind

International cooperation is key to get equal access to COVID-19 vaccines

Research shows how antibodies attach to and block Zika virus

AI-mediated analysis of vaccinated patients affirms safety of SARS-CoV-2 vaccines

Study of children hospitalized with COVID-19 shows 2% mortality

New vaccine, enhanced surveillance needed to combat childhood pneumonia

Travel bans are effective only in the first phases of pandemic

New approach can reduce unnecessary evaluations of swollen lymph nodes after COVID-19 vaccination

Lab study of South African SARS-CoV-2 variant and Moderna vaccine: reduced neutralization, but still protective

Full characterization of mammalian-produced SARS-CoV-2 receptor binding domains

Study takes a closer look at the impact of COVID-19 pandemic on dental hygienists

Survey finds highest ever vaccination rates during the 2020-2021 flu season

GW team to play a role in Sanofi COVID-19 vaccine clinical trial

COVID-19 hospitalizations still high in England despite recent decline in cases, says study

World's largest resource of genome variation data on malaria parasites released

Researchers explore how N501Y mutation in SARS-CoV-2 increases viral transmissibility

Event guide: The 5th mRNA-Based Therapeutics Summit Europe eBook

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Vaccine News and Research

Latest Vaccine News and Research

Event guide: The 5th mRNA-Based Therapeutics Summit Europe eBook

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Newsletters you may be interested in